Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Update: Lilly Makes $7bn Bid for in Vivo CAR-T Firm Kelonia
Eli Lilly has confirmed a $3.25 billion upfront offer for Kelonia Therapeutics, with milestone payments that could lift the total value to $7 billion. Kelonia’s in vivo CAR‑T candidate KLN‑1010 demonstrated MRD‑negative responses in a four‑patient early‑stage study, highlighting the promise of off‑the‑shelf cell therapies. The deal marks the largest in‑vivo CAR‑T acquisition to date, building on Lilly’s recent string of oncology‑focused purchases funded by its booming obesity‑diabetes franchise.
One Year In: How Medtech Companies Are Coping with Tariff Challenges
One year after President Trump’s “Liberation Day” tariffs on China, Mexico, Canada, the EU and other partners, medtech firms are still feeling the financial sting. Unlike pharma, device makers have not reshored at scale, opting instead to absorb costs and...
Nektar’s Long-Term Mid-Stage Alopecia Data Fuel Phase 3 Plans
Nektar Therapeutics reported that its IL-2 variant rezpegaldesleukin achieved modest efficacy and safety signals in the long‑term extension of a previously failed Phase 2b alopecia areata trial, barely meeting Wall Street expectations. The data revive confidence in the program and...
Maternal Health in War: UNFPA’s Faye Callaghan on Ukraine’s Frontline Birth Crisis
UNFPA maternal‑health specialist Faye Callaghan describes how Ukraine’s war has turned childbirth into a high‑risk, unpredictable operation. Bunkerized maternity wards are being repurposed from underground shelters to protect mothers and newborns from bombardment. Recent UNFPA data show a rise in...
![[Comment] Treatment of Uncomplicated Lower Urinary Tract Infections in Women](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/89a267f4f4bf9d67549ac574f13354b4.webp)
[Comment] Treatment of Uncomplicated Lower Urinary Tract Infections in Women
Uncomplicated lower urinary tract infections affect roughly half of women at some point, making them a leading cause of outpatient antibiotic prescriptions. While single‑dose fosfomycin trometamol has been favored for convenience, recent randomized data—including the 2018 Huttner trial and the...
STAT+: Extended Use of Nektar Therapeutics Drug Shows Promise in Alopecia
Nektar Therapeutics announced that its experimental oral drug rezpeg produced significant hair regrowth in patients with severe alopecia areata. After a year of treatment, 27% of participants reached a SALT Score 20, meaning at least 80% of the scalp was covered...
Novo Nordisk Reports Positive P-III (HIBISCUS) Study Data for Etavopivat in Sickle Cell Disease
Novo Nordisk announced that its oral pyruvate kinase activator etavopivat met both primary endpoints in the Phase III HIBISCUS trial for sickle cell disease. In 385 patients aged 12 and older, the drug reduced vaso‑occlusive crisis (VOC) rates by 27% and...
From Test to Treatment: How Quality Diagnostics Improve Patient Care
SYNLAB Nigeria is positioning diagnostic quality as a core component of patient care by operating over 35 labs nationwide and offering a fully digital test‑ordering and results platform. The company’s ISO 15189 accreditation mandates continuous auditing, equipment calibration and staff competency,...
This Missing Vitamin Could Stop Cancer Cells in Their Tracks
Researchers at the University of Lausanne discovered that vitamin B7 (biotin) is essential for the mitochondrial enzyme pyruvate carboxylase, which lets cancer cells sidestep their usual glutamine addiction. When biotin is removed, the enzyme stalls, cutting off an alternative fuel pathway...
Health Visitors Call for Limits on 'Impossible' 1,000-Family Caseloads
The Institute of Health Visiting (iHV) is urging England to set safe‑staffing limits after a 45% drop in health visitor numbers leaves many handling more than 1,000 families each. The workforce has fallen from 10,200 to 5,575 in a decade,...
From Near-Exit to Times Square AI Healthcare Spotlight
I never thought I’d say this: I almost left medicine. Today my work in AI/Robotics-powered healthcare transformation is being recognised in Times Square, linked to a Health 2.0 award where I spoke on safe AI integration. Airs today (Mon Apr 20,...
A Future Where Coffee Helps Fight Cancer? Research Suggests It's Possible
Scientists at Texas A&M have engineered caffeine‑responsive proteins, called caffebodies, that act as an on/off switch for CRISPR gene‑editing tools. The system activates with just 20 mg of caffeine—about one‑fifth of a typical coffee—and deactivates as caffeine clears, with rapamycin providing...
🌊 Is Marijuana Dangerous?
The blog notes that marijuana legalization has exploded—38 states now permit medical use and 24 plus Washington, D.C. allow recreation—while THC potency has surged from 1‑4% in the 1970s to the mid‑20s today, with some extracts topping 90%. A recent...
Brainjo Secures €2m in Seed Funding for VR Mental Health Tech
German startup brainjo announced a €2 million (≈$2.2 million) seed round to develop its first virtual‑reality Digital Health Application (DiGA). The VR‑based tool is designed as a prescribable adjunct for children with ADHD, allowing at‑home use alongside traditional psychotherapy. Funding was led...
New Protections in Checklist for Patients, Donors, and Blood
The College of American Pathologists (CAP) has updated its transfusion‑medicine accreditation checklist for 2026, adding new safety controls that affect every hospital blood bank in the United States. The revisions require repeat or historical ABO/Rh verification for all compatibility‑testing methods,...
AstraZeneca Reports Positive P-III (MIRANDA) Data for Tozorakimab in COPD
AstraZeneca announced that its anti‑IL‑33 antibody tozorakimab achieved its primary endpoint in the Phase III MIRANDA trial, delivering a statistically significant reduction in the annualised rate of moderate‑to‑severe COPD exacerbations. The double‑blind study enrolled 1,454 patients receiving standard inhaled therapy and...
Vaginal Drug Delivery Had A Funding Problem—Merck Changed That
Calla Lily Clinical Care’s tampon‑shaped vaginal drug delivery platform, Callavid, has secured a strategic collaboration with Merck to accelerate clinical development for IVF luteal‑phase support and miscarriage prevention. The device, cleared under FDA 510(k) and patented in 14 countries, promises...
AZ Is Three for Three with COPD Hope Tozorakimab
AstraZeneca’s anti‑IL‑33 antibody tozorakimab has succeeded in all three pivotal Phase 3 COPD trials, showing a statistically significant reduction in moderate‑to‑severe exacerbations. The MIRANDA study confirmed benefit with biweekly dosing, while OBERON and TITANIA validated once‑monthly regimens. These results place AZ...
Latin American Study Links Teen Social‑Media Use to Attention, Emotion and Identity Challenges
A study highlighted in the Latin American Post finds that intensive social‑media use among teens in the region correlates with a thinner cerebral cortex and heightened attention, emotional and identity struggles. The findings raise alarms for parents, schools and policymakers...
WHO Webinar Highlights Health Sector Strategies to Empower Fathers in Child Care
The World Health Organization, together with the Child Health Task Force and the ECD Action Network, hosted a webinar outlining how health systems can embed father‑specific caregiving resources into routine services. Case studies from Jordan and the United Republic of...
Novo Nordisk’s Sickle Cell Therapy Hits in Phase 3, but Data Lag Expectations
Novo Nordisk announced that its oral sickle‑cell drug etavopivat met its primary endpoint in a Phase 3 trial, showing a statistically significant reduction in painful vaso‑occlusive crises. The study, however, fell short of the ambitious efficacy and safety benchmarks the...
Omada Health Study Shows 6% Weight Loss and Muscle Preservation on GLP-1 Program
Omada Health released a 12‑week study of 245 adults with obesity showing its GLP‑1 Care Track delivered 6.0% average weight loss, a 3.3‑point drop in body‑fat percentage and a threefold rise in muscle‑mass share compared with a control group. The...
REITs Own One‑Fifth of U.S. Senior Housing, Raising Care Quality Concerns
Real‑estate investment trusts have bought roughly 20% of the nation’s senior‑housing portfolio and a sixth of its nursing homes, prompting lawsuits over resident deaths and renewed scrutiny of their influence on care quality. Critics argue that rent‑focused lease terms and...
United Therapeutics Supports 120+ Experts at Quantum Biology Forum
United Therapeutics CEO Martine Rothblatt funded the inaugural Quantum Biology Forum, drawing over 120 scientists, industry leaders, and innovators to explore quantum mechanics as a therapeutic target. The two‑day event, hosted by Northwell Health, examined quantum effects such as electron...
Haryana Drugs Regulator Reports Fake Mounjaro Seizure in Gurugram: Eli Lilly
Eli Lilly disclosed that Haryana’s drug regulator seized roughly ₹70 lakh (about $85,000) of counterfeit Mounjaro injections in Gurugram. The company said it is actively supporting the investigation and praised the authorities’ enforcement action. Mounjaro, a GLP‑1 drug used for obesity, has...
UCB to Acquire Neurona Therapeutics for $650M, Adding Regenerative Epilepsy Asset
UCB announced a definitive agreement to acquire Neurona Therapeutics for $650 million upfront and up to $500 million in milestones, adding the regenerative cell therapy NRTX‑1001 to its epilepsy pipeline. The deal, expected to close by Q2 2026, expands UCB’s portfolio into advanced‑therapy...
Innate Pharma to Present P-II (MATISSE) Interim Data of IPH5201 in NSCLC at AACR 2026
Innate Pharma will present interim Phase‑II (MATISSE) data for its anti‑CD39 antibody IPH5201 in resectable non‑small cell lung cancer (NSCLC) at the AACR 2026 meeting. The analysis of 40 patients shows a pathological complete response (pCR) of 35.7% in tumors...
CNET Highlights Top FDA-Cleared Red Light Therapy Devices as Market Nears $660 Million by 2032
CNET released its 2026 roundup of FDA-cleared red light therapy devices, naming the Shark CryoGlow mask, Smoothskin DuoLux patches, iRestore Elite hair helmet, and Clearlight Personal Tower panel as the top picks. The guide cites rapid market growth from $421 M...
WINCEE Launch: Women’s Health Research Top of the Agenda
At the NutraFood Poland event, WINCEE co‑chairs Ewa Hudson and Agnieszka Anielska highlighted the massive economic upside of closing the women’s health gap, estimating a $1 trillion annual boost to the global economy. They pointed out that women account for only...
Certain Drugs Like SGLT2 Inhibitors Cut Mortality Risk
A 2024 study on half a million UK individuals analyzed the mortality effects of 406 medications 92% were seen to be associated with increased mortality risk because of the underlying diseases. However, 14 were surprisingly associated with reduced mortality. An overview by...
Measles Surge Pushes Anti‑vaxxers to Adopt MMR
Bloomberg: “As Measles Takes Toll on Kids, Anti-Vaxxers Have Change of Heart: Enough parents are quietly embracing the MMR that it’s helping to slow the outbreaks.” https://t.co/HLcfl5flNY https://t.co/tuE89RwR4F
Eli Lilly in Advanced Talks to Buy Kelonia Therapeutics for over $2 Billion
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for over $2 billion, according to the Wall Street Journal. The deal, which may include milestone payments, could be announced as early as Monday and would bolster Lilly’s oncology pipeline. Shares...
Wearable Health Data Boom Drives Doctors Toward New Big‑Data Analytics
A surge in consumer wearables—now a $100 bn industry—has clinicians scrambling to integrate continuous biometric streams into medical workflows. Doctors cite raw data overload, new AI‑driven coaching tools and emerging analytics platforms as essential to turn wrist‑ and finger‑sourced metrics into...
Nanobiotix's Nanoprimer Boosts LNP‑DNA Immunotherapy Bioavailability, Cuts Toxicity
Nanobiotix unveiled preclinical results that its Nanoprimer platform, given before lipid‑nanoparticle DNA immunotherapies, markedly increases systemic exposure and reduces hepatic toxicity in mice. The data, presented at the 2026 AACR meeting, could unlock more effective LNP‑based cancer treatments.
As UK Regulators Tighten the Rules on Mental Health Apps, the Next Test Is Post-Treatment Monitoring
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has introduced robust guidance that forces mental‑health apps to meet minimum safety standards, display a CE or UKCA mark and be listed on an official register. The new rules also give...
Contributor: Focus on the Real Causes of the Shortage in Hormone Treatments
U.S. pharmacies have struggled to fill estradiol patch prescriptions, prompting media narratives that blame a surge in menopause hormone demand. In reality, usage of hormone therapy has hovered around 5% of menopausal women, far from unprecedented levels. The shortage is...
GLP-1 May Only Be the Beginning, Not the End of the Story
Researchers led by Richard DiMarchi and Matthias Tschöp published a paper in Molecular Metabolism showing that triple agonist retatrutide can drive weight loss even when GLP‑1 signaling is blocked. Their preclinical work demonstrates that co‑activating GIP and glucagon receptors produces...
Freudenberg Medical Launches ISO Class 5 Cleanroom for Biopharma
Freudenberg Medical announced CleanAssure, an ISO 5 controlled cleanroom that delivers washed, dried and gamma‑sterilized single‑use assemblies for biopharma customers. The service expands the company’s portfolio beyond component manufacturing to include validated cleaning and sterilization under cGMP conditions. By integrating this...
Pressing for a POC Testing Model Amid High STI Rates
Point‑of‑care (POC) testing for sexually transmitted infections is being championed as a critical tool to curb rising STI rates, especially among youth and marginalized communities. Dr. Aniruddha Hazra highlighted that while overall diagnostic rates have improved, groups such as LGBTQ+,...
Scientists Say This Star-Shaped Brain Cell Holds the Key to Curing Anxiety and PTSD
Recent research reclassifies astrocytes—once dismissed as "brain glue"—as active regulators of neuronal function. A Nature study shows that stress‑induced reactive astrocytes can either shield neurons or release toxic factors, influencing neurodegenerative disease progression. Separate experiments demonstrate that manipulating astrocyte activity...
AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories
Patients are increasingly turning to AI-driven services to translate their laboratory test results, often before seeing a physician. Startups and wellness firms offer subscription models that provide simplified explanations and suggested actions, with pricing ranging from free tiers to several...
Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own
Oscar Health unveiled the Lucie Health Marketplace, an AI‑powered platform that aggregates every major individual health‑insurance plan along with supplemental and ancillary coverage. The service instantly quotes, enrolls, and renews policies from carriers such as UnitedHealthcare, Cigna, Ambetter, and Aflac,...
Howard De Walden Lets Harley Street Space for 10M Healthcare Surgery Centre
10M Healthcare has leased No 1 Harley Street from the Howard de Walden Estate to build a £100 m (~$125 m) ambulatory surgery centre. The ASC will feature five operating theatres, GP consultation rooms, screening services and wellbeing suites, and is slated to open...
Knowledge and Adherence to Palliative Care Practices
A quantitative survey of physicians, nurses, therapists and other staff at a Brazilian tertiary hospital revealed substantial gaps in knowledge and perception of palliative care (PC). About one‑quarter of respondents did not know the hospital’s PC services, with statistically significant...
Beyond the "Safe" Narrative
A retrospective study by Jacobs et al. examined directed blood donations at Vanderbilt University Medical Center from 2024 to 2025, focusing on patients who rejected standard inventory over COVID‑19 vaccine concerns. The analysis found a modest rise in such donations...
Reti̇nal and Choroi̇dal Mi̇crovascular Changes İn Hemodi̇alysi̇s and Peri̇toneal Di̇alysi̇s: A Comparati̇ve Oct and Oct-A Study
Researchers used OCT and OCTA to compare retinal and choroidal changes in patients undergoing hemodialysis (HD) versus peritoneal dialysis (PD). Across 84 eyes from 46 patients, central macular thickness and subfoveal choroidal thickness decreased significantly after each dialysis session, while...
Georgetown Engineers Pectin-Based Bone Grafts to Replace Metal Implants
Georgetown University researchers have engineered a 3D‑printed bone graft that combines pectin—a food‑grade polysaccharide—with hydroxyapatite layers to mimic natural bone architecture. The pectin matrix can be printed at room temperature, creating a porous scaffold that promotes nutrient flow and cell...
NCSC Outlines Coordinated Plan to Boost NHS Cyber Resilience
The UK National Cyber Security Centre (NCSC) unveiled a coordinated plan to strengthen cyber resilience across the NHS, built on 18 months of government‑industry collaboration. The strategy pivots on five pillars, including the Active Cyber Defence 2.0 pilot, software‑supply‑chain hardening,...
The Hidden Cost of Healthcare Data Breaches
Health‑insurance data breaches have exposed over 400 million identities since 2021, yet plan sponsors, TPAs and carriers provide no post‑breach fraud protection. HIPAA settlements can reach $25,000 per stolen identity, while remediation averages more than $13,000 per individual, creating a lucrative...
Can Positive Expectations Tune the Immune System?
Researchers conducted a preregistered, double‑blind RCT with 85 healthy adults to test whether fMRI neurofeedback can boost reward‑related brain activity and affect immune response to a hepatitis B vaccine. Participants who learned to up‑regulate the ventral tegmental area (VTA) showed a...